Cargando…
A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis
BACKGROUND: The etiology of rheumatoid arthritis (RA) remains poorly understood. Early and accurate diagnosis still difficult to achieve. Inflammatory related molecules released into the circulation such cytokines and exosome-derived microRNAs (exomiRNAs) could be good candidates for early diagnosis...
Autores principales: | Rodríguez-Muguruza, Samantha, Altuna-Coy, Antonio, Castro-Oreiro, Sonia, Poveda-Elices, Maria José, Fontova-Garrofé, Ramon, Chacón, Matilde R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636106/ https://www.ncbi.nlm.nih.gov/pubmed/34868079 http://dx.doi.org/10.3389/fimmu.2021.790880 |
Ejemplares similares
-
Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy
por: Kangas, Reeta, et al.
Publicado: (2017) -
Exosomal microRNAs (exomiRs): Small molecules with a big role in cancer
por: Bhome, Rahul, et al.
Publicado: (2018) -
Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment
por: Jahromi, Faride Nam Avar, et al.
Publicado: (2023) -
A serum metabolic biomarker panel for early rheumatoid arthritis
por: Rodríguez-Muguruza, Samantha, et al.
Publicado: (2023) -
Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness
por: Ruiz-Plazas, Xavier, et al.
Publicado: (2019)